US Food and Drug Administration Perspective on "Mortality and Paclitaxel-Coated Devices: An Individual Patient Data Meta-Analysis"

Circulation. 2020 Jun 9;141(23):1870-1871. doi: 10.1161/CIRCULATIONAHA.120.047376. Epub 2020 Jun 8.

Authors

Sara Royce¹, Adrijo Chakraborty², Yu Zhao²

Affiliations

¹ Office of Cardiovascular Devices (S.R.), Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
² Office of Clinical Evidence and Analysis (A.C., Y.Z.), Office of Product Evaluation and Quality, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.

PMID: 32511000
DOI: 10.1161/CIRCULATIONAHA.120.047376

No abstract available

Keywords: Editorials; paclitaxel; peripheral arterial disease; risk.

Publication types

Editorial
Comment

MeSH terms

Angioplasty, Balloon*
Humans
Paclitaxel / adverse effects
Peripheral Arterial Disease*
United States / epidemiology
United States Food and Drug Administration

Substances

Paclitaxel